Literature DB >> 28063070

Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index.

Marco Di Carlo1, Valentina Lato2, Andrea Di Matteo2, Marina Carotti3, Fausto Salaffi2.   

Abstract

The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is an inclusive questionnaire, able to describe the total impairments and restrictions due to axial spondyloarthritis (axSpA). Considering the relationship between ASAS HI and the Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP, the aim of this study is to establish the ASAS HI cut-off values for functioning categories employing the ASDAS-CRP disease activity states in axSpA patients. ASAS HI and ASDAS-CPR were obtained from 140 consecutive axSpA patients, divided in the four ASDAS-CRP disease activity categories. High and very high disease activity were considered together. The ASAS HI cut-offs were obtained from the arithmetic mean, rounded off to the closest whole number, of the 75th percentile mean value of a lower rank and the 25th percentile mean value of the adjacent higher rank. This approach was applied in the transition from inactive disease and moderate disease activity, and in the transition from moderate disease activity and high/very high disease activity. Twenty-three patients were classified as having inactive disease, 36 were classified as having moderate disease activity, and 81 were in a high/very high disease activity state. Using the approach of the 75th-25th percentile mean values of adjacent disease activity states, the ASAS HI cut-offs resulted: ≤4 to dinstinguish a normal functioning, >4 and ≤8 to distinguish a moderate impairment of functioning, and >8 to distinguish a severe impairment of functioning. ASAS HI seems a reliable tool to define functioning categories in patients with axSpA.

Entities:  

Keywords:  ASAS HI; Axial spondyloarthritis; Cut-offs; Disease activity; Functioning categories; Health-related quality of life

Mesh:

Year:  2017        PMID: 28063070     DOI: 10.1007/s00296-016-3642-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  Impact of ankylosing spondylitis on work in patients across the UK.

Authors:  E L Healey; K L Haywood; K P Jordan; A Garratt; J C Packham
Journal:  Scand J Rheumatol       Date:  2010-08-20       Impact factor: 3.641

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.

Authors:  Irene van Echteld; Alarcos Cieza; Annelies Boonen; Gerold Stucki; Jane Zochling; Jürgen Braun; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2006-10-15       Impact factor: 4.666

Review 4.  Spondyloarthritis.

Authors:  Maxime Dougados; Dominique Baeten
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.

Authors:  M Rudwaleit; R Landewé; D van der Heijde; J Listing; J Brandt; J Braun; R Burgos-Vargas; E Collantes-Estevez; J Davis; B Dijkmans; M Dougados; P Emery; I E van der Horst-Bruinsma; R Inman; M A Khan; M Leirisalo-Repo; S van der Linden; W P Maksymowych; H Mielants; I Olivieri; R Sturrock; K de Vlam; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health.

Authors:  A Boonen; J Braun; I E van der Horst Bruinsma; F Huang; W Maksymowych; N Kostanjsek; A Cieza; G Stucki; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.

Authors:  Monika M Schoels; Daniel Aletaha; Farideh Alasti; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2015-08-12       Impact factor: 19.103

10.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

View more
  3 in total

1.  Validity and interpretability of the QuickDASH in the assessment of hand disability in rheumatoid arthritis.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Sonia Farah
Journal:  Rheumatol Int       Date:  2018-12-03       Impact factor: 2.631

2.  Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Şebnem Ataman; Yeşim Garip; Kemal Nas; Fikriye Figen Ayhan Fikriye Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Murat Birtane; Derya Soy Buğdayci; Erhan Çapkin; Remzi Çevik; Tuncay Duruöz; Gülcan Gürer; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Ömer Kuru; Meltem Alkan Melikoğlu; Erhan Özdemirel; Sumru Özel; Aylin Rezvani; İlhan Sezer; İsmihan Sunar; Gürkan Yilmaz
Journal:  Arch Rheumatol       Date:  2018-02-14       Impact factor: 1.472

3.  Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19.

Authors:  Rosario Foti; Giorgio Amato; Roberta Foti; Elisa Visalli
Journal:  Front Public Health       Date:  2020-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.